J&J Adds Second Anti-BCMA Myeloma Therapy In US With Tecvayli Approval

Could Offer Option As CAR-T Manufacturing Lags

 
• By Mandy Jackson
  
Spectrum of stacked multi-colored wooden blocks
Tecvayli is another building block in J&J/Janssen's growing multiple myeloma portfolio • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip